Cooperative AgreementPostedDiscretionary

Restoring Joint Health and Function to Reduce Pain (RE-JOIN) 2.0

National Institutes of Health
RFA-AR-26-006
Application Deadline
Days Remaining
Until deadline
Award Ceiling
Total Program Funding

Grant Opportunity Analysis

The National Institutes of Health (NIH) is announcing a funding opportunity titled "Restoring Joint Health and Function to Reduce Pain (RE-JOIN) 2.0," aimed at advancing research on joint pain and its underlying mechanisms. This initiative, part of the NIH Helping to End Addiction Long Term (HEAL) initiative, seeks to enhance the understanding of joint innervation and pain through multidisciplinary collaborations, focusing on various articular and peri-articular tissues. The program is particularly significant for addressing musculoskeletal and rheumatic conditions associated with joint pain, with an expected eight awards to be made. Interested applicants can reach out to the National Institute of Arthritis and Musculoskeletal and Skin Diseases via email at NIAMS_PAIN@mail.nih.gov for further information. The estimated synopsis post date is October 1, 2026, with applications expected to close by December 1, 2026, and project start dates anticipated for September 1, 2027.

Eligible Applicants

Others
Additional Eligibility Information

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).

Grant Documents

0 Files
No documents available for this grant.

Related Grant Opportunities

Project Timeline

postedOriginal Opportunity PostedJan 22, 2026

Funding Details

Expected Awards
8
No cost sharing required

Agency & Classification

Agency
National Institutes of Health(HHS-NIH11)
Funding Category
Health
Funding Instrument
Cooperative Agreement

Grantor Contact

Name
National Institute of Arthritis and Musculoskeletal and Skin Diseases

CFDA Numbers

93.846

Official Sources